Causes of Death and Comorbidities in Adult Patients With Late-Onset Pompe Disease: A French Pompe Registry Retrospective Study. [PDF]
Chitimus DM +26 more
europepmc +1 more source
Latest Advancements in Treatment Options for Infantile-Onset Pompe Disease: A Comprehensive Narrative Review. [PDF]
Khan M +8 more
europepmc +1 more source
Management of hypersensitivity in a patient with late-onset Pompe disease experiencing recurrent infusion-related reactions. [PDF]
Mendelsohn DH +4 more
europepmc +1 more source
Comparing the efficacy of cipaglucosidase alfa plus miglustat with alglucosidase alfa for late-onset Pompe disease: an expanded network meta-analysis utilizing patient-level and aggregate data. [PDF]
Fu S +8 more
europepmc +1 more source
Infantile-onset Pompe disease entering adulthood: Insights from 2 decades of enzyme replacement therapy experience. [PDF]
Regmi N +11 more
europepmc +1 more source
Early initiation of enzyme replacement therapy as facilitated by newborn screening improves health outcomes among patients with infantile-onset Pompe disease. [PDF]
Desai AK +12 more
europepmc +1 more source
Determination of the Epitopes of Alpha-Glucosidase Anti-Drug Antibodies in Pompe Disease Patient Plasma Samples. [PDF]
Petrotchenko EV, Hahn A, Borchers CH.
europepmc +1 more source
Extensive digital health technology assessment detects subtle motor impairment in mild and asymptomatic Pompe disease. [PDF]
Pilotto A +17 more
europepmc +1 more source

